A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32552023.
- Also identified by DOI 10.2105/AJPH.2020.305696 and PMC identifier 7349461.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted PDMPs, and they have received strong bipartisan legislative support. This article explores the history of PDMPs, tracking their evolution from paper-based administrative databases in the early 1900s to modern-day electronic systems that intervene at the point of care. We focus on two questions: how did PDMPs become so widely adopted in the United States, and how did they gain popularity as an intervention in the contemporary opioid crisis? Through this historical approach, we evaluate what PDMPs reflect about national drug policy and broader cultural understandings of substance use disorder in the United States today. (<i>Am J Public Health.</i> 2020;110:1191-1197. 10.2105/AJPH.2020.305696).
Medical subject headings
- Prescription Drug Misuse
- Prescription Drug Monitoring Programs
- Public Health